| Date Filed | Type | Description |
| 06/28/2021 |
REVOKED
| Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]: |
| 01/10/2019 |
GN
| Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture |
| 12/10/2018 |
GN
| Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada |
| 12/07/2018 |
GN
| Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale |
| 12/04/2018 |
GN
| Emerald Joint Venture Receives Licenses from Health Canada to Sell Proprietary Products Supporting the Endocannabinoid System |
| 11/30/2018 |
GN
| Emerald Health Therapeutics Reports 3rd Quarter 2018 Financial Results and Provides Corporate Update |
| 11/28/2018 |
GN
| Emerald Health Therapeutics Announces Executive Chairman Avtar Dhillon Appointed as President; CEO Chris Wagner Steps Down |
| 11/22/2018 |
GN
| Emerald Health Therapeutics Appoints Agro-Biotech President |
| 11/22/2018 |
GN
| Emerald Health Therapeutics nomme le président d'Agro-Biotech |
| 11/07/2018 |
GN
| Emerald Health Therapeutics Fulfilling Supply Commitments with Provincial Adult-Use Cannabis Shipments |
| 10/10/2018 |
GN
| Emerald Health Therapeutics' Subsidiary Northern Vine Receives International Government Approvals and Completes Import and Export of Cannabis Oils for Research & Development |
| 10/09/2018 |
GN
| Emerald Health Therapeutics' Wholly Owned Subsidiary Northern Vine to Participate in Series of Cannabis Testing Seminars Hosted by Thermo Fisher Scientific |
| 10/03/2018 |
GN
| Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products |
| 09/26/2018 |
GN
| Emerald Health Therapeutics Secures Long-term Supply of Hemp for CBD Extraction |
| 09/10/2018 |
GN
| Emerald Health Therapeutics Named as Cannabis Supplier by Newfoundland Labrador Liquor Corporation to Provide Adult-Use Cannabis Products |
| 09/07/2018 |
GN
| Emerald Health Therapeutics Confirms Supply Agreement with Ontario Cannabis Retail Corporation to Supply Adult-Use Cannabis Products |
| 09/06/2018 |
GN
| Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms' Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis Growing Facilities in the World |
| 08/30/2018 |
GN
| Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update |
| 08/27/2018 |
GN
| Emerald Health Therapeutics Signs Term Sheet to Access Large-Scale Extraction, Softgel Production, and New Product Development Capabilities Through Strategic Alliance with Factors Group of Nutritional Companies |
| 08/24/2018 |
GN
| Emerald Health Therapeutics Engages Acorn Management Partners for Investor Relations |
| 08/23/2018 |
GN
| Emerald Health Therapeutics Announces Amendment to Pure Sunfarms' Cultivation License, Substantially Expanding Cannabis Production Area to Approximately 420,000 Square Feet |
| 08/15/2018 |
GN
| Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada |
| 08/14/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 08/14/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/30/2018 |
GN
| Emerald Health Therapeutics' Cannabis Joint Venture Pure Sunfarms Receives Sales License from Health Canada for 1.1 Million Square Foot Greenhouse |
| 07/27/2018 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/25/2018 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
| 07/19/2018 |
GN
| Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation |
| 07/12/2018 |
GN
| Emerald Health Therapeutics Updates on its Differentiated Strategy and Progress |
| 06/27/2018 |
GN
| Emerald Health Therapeutics Announces Amendment to Pure Sunfarms' Cultivation License, Substantially Expanding Cannabis Production Area to 225,000 Square Feet |
| 06/19/2018 |
GN
| Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada |
| 05/29/2018 |
GN
| Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update |
| 05/21/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
| 05/15/2018 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
|